Terms: = Thyroid cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Prognosis
18 results:
1. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
Lin X; Su H; Huo J; Zhang F
Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and pathological features analysis of invasive breast cancer with microcalcification.
Tian Y; Zhao L; Gui Z; Liu S; Liu C; Yu T; Zhang L
Cancer Med; 2023 May; 12(10):11351-11362. PubMed ID: 36971046
[TBL] [Abstract] [Full Text] [Related]
3. HIF-1α and Caspase-3 expression in aggressive papillary thyroid carcinoma.
Zhang L; Shi B; Hu M; Qian L
World J Surg Oncol; 2022 Nov; 20(1):353. PubMed ID: 36329448
[TBL] [Abstract] [Full Text] [Related]
4. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.
Liu W; Ye X; He L; Cheng J; Luo W; Zheng M; Hu Y; Zhang W; Cao Y; Ran H; Yang L
J Nanobiotechnology; 2021 Dec; 19(1):432. PubMed ID: 34930301
[TBL] [Abstract] [Full Text] [Related]
5. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract] [Full Text] [Related]
6. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
[TBL] [Abstract] [Full Text] [Related]
7. Assessment of circulating HISLA as a potential biomarker for breast cancer diagnosis and prognosis.
Hu H; Hu J; Yang Y; Zhou W; Ye C
Clin Exp Med; 2021 Feb; 21(1):29-34. PubMed ID: 33123839
[TBL] [Abstract] [Full Text] [Related]
8. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Watanabe A; Harimoto N; Yokobori T; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Handa T; Oyama T; Higuchi T; Shirabe K
Int J Clin Oncol; 2020 Feb; 25(2):322-329. PubMed ID: 31612350
[TBL] [Abstract] [Full Text] [Related]
9. hif1a-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer.
Wang Y; Zhang G; Han J
J Cell Biochem; 2019 Jun; 120(6):10513-10518. PubMed ID: 30635931
[TBL] [Abstract] [Full Text] [Related]
10. PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α-Mediated Epithelial-Mesenchymal Transition Process in Breast cancer.
Fu D; He C; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Physiol Biochem; 2018; 51(5):2434-2444. PubMed ID: 30537744
[TBL] [Abstract] [Full Text] [Related]
11. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract] [Full Text] [Related]
13. Expression of Hypoxia-Associated Protein HIF-1α in Follicular thyroid cancer is Associated with Distant Metastasis.
Klaus A; Fathi O; Tatjana TW; Bruno N; Oskar K
Pathol Oncol Res; 2018 Apr; 24(2):289-296. PubMed ID: 28474313
[TBL] [Abstract] [Full Text] [Related]
14. Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis.
Lodewijk L; van Diest P; van der Groep P; Ter Hoeve N; Schepers A; Morreau J; Bonenkamp J; van Engen-van Grunsven A; Kruijff S; van Hemel B; Links T; Nieveen van Dijkum E; van Eeden S; Valk G; Borel Rinkes I; Vriens M
Oncotarget; 2017 Apr; 8(17):28650-28659. PubMed ID: 28404916
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological Features and prognosis of Papillary thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract] [Full Text] [Related]
16. Circulating Myeloid-Derived Suppressor Cells Predict Differentiated thyroid cancer Diagnosis and Extent.
Angell TE; Lechner MG; Smith AM; Martin SE; Groshen SG; Maceri DR; Singer PA; Epstein AL
Thyroid; 2016 Mar; 26(3):381-9. PubMed ID: 26756227
[TBL] [Abstract] [Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.
Bolignano D; Donato V; Lacquaniti A; Fazio MR; Bono C; Coppolino G; Buemi M
Cancer Lett; 2010 Feb; 288(1):10-6. PubMed ID: 19540040
[TBL] [Abstract] [Full Text] [Related]
18. Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway.
Liu R; Li Z; Bai S; Zhang H; Tang M; Lei Y; Chen L; Liang S; Zhao YL; Wei Y; Huang C
Mol Cell Proteomics; 2009 Jan; 8(1):70-85. PubMed ID: 18723843
[TBL] [Abstract] [Full Text] [Related]
